Godsey & Gibb Inc’s Chimerix, Inc. CMRX Stock Holding History

Godsey & Gibb Inc’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-300	Closed	-$1K	–	341
2022 Q3	$1K	Buy	+300	New	+$673	﹤0.01%	88

Other funds holding CMRX

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Godsey & Gibb Inc's CMRX Position: Q4 2022 in Review

Godsey & Gibb Inc sold out of Chimerix, Inc. (CMRX) in Q4 2022, closing a stake of 300 shares — an estimated $1K sold.

Godsey & Gibb Inc first reported a position in CMRX in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 108 funds tracked by Wall St. Rank hold CMRX as of Q4 2022.

Godsey & Gibb Inc reported no remaining Chimerix, Inc. position as of Q4 2022 after selling out during the quarter.
Godsey & Gibb Inc sold 300 Chimerix, Inc. shares in Q4 2022, an estimated $1K.
Godsey & Gibb Inc first reported a position in Chimerix, Inc. in Q3 2022 and held it in 1 quarter.
Godsey & Gibb Inc's Chimerix, Inc. position peaked at $1K in Q3 2022.
108 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q4 2022.

Based on Godsey & Gibb Inc's 13F filing for Q4 2022, filed 18 Jan 2023.